Sangamo to buy Ceregene
This article was originally published in Scrip
Executive Summary
Richmond, California-based Sangamo is to buy privately owned Ceregene, based in San Diego, for an undisclosed sum. Through the deal, Sangamo will acquire a portfolio of adeno-associated virus (AAV) assets.